We place the field by the two powers that decide this market — control of how a customer is acquired and distributed, and the capital and scale that fund the chase. The platforms cluster top-right, where owned acquisition and balance-sheet depth concentrate; Rugiet sits low on both, a single-vertical brand buying traffic in the same auction as multi-billion-dollar incumbents, with one revenue line to recover the cost. Bubble size is the composite structural score. Hover any brand to read where it stands. Click to pin.
The platforms — Hims & Hers on roughly $2.35B, Ro on a multi-condition base, and GoodRx at the top of the cash-pay funnel — cluster in the upper-right, where owned acquisition channels and balance-sheet depth both run high. That corner is where the customer is won before the product is compared: brand search, direct traffic, and acquisition cost recovered across many conditions and years. Generic sildenafil and tadalafil through retail and Amazon Pharmacy anchor the price floor at $10–21 a month. Rugiet enters from the opposite corner, near the origin on both axes, buying customers in the same auction (paid social ~21%, paid keywords ~19% of visits, company-asserted) with one revenue line to recover a cost a scaled competitor pays near $929 and earns back across its whole platform. Where Rugiet earns its place is off this map — the 3-in-1 dissolvable tablet is the most novel product in the focused set. The map shows the auction; the rank shows the gap.